Prospective evaluation of anthracycline-related early cardiac damage: how do we monitor it?

J Clin Oncol. 2001 Nov 15;19(22):4269-70. doi: 10.1200/JCO.2001.19.22.4269.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects*
  • Antibiotics, Antineoplastic / therapeutic use
  • Breast Neoplasms / blood
  • Breast Neoplasms / drug therapy
  • Epirubicin / adverse effects*
  • Epirubicin / therapeutic use
  • Female
  • Heart / drug effects*
  • Humans
  • Middle Aged
  • Natriuretic Peptide, Brain / blood
  • Prospective Studies
  • Radionuclide Ventriculography
  • Ultrasonography
  • Ventricular Dysfunction, Left / blood
  • Ventricular Dysfunction, Left / chemically induced*
  • Ventricular Dysfunction, Left / diagnostic imaging

Substances

  • Antibiotics, Antineoplastic
  • Natriuretic Peptide, Brain
  • Epirubicin